Empagd-M

Therapeutic Segment:
Anti-diabetic

Generic Name:
Empagliflozin/Metformin

Description:
Empagd-M tablets contain two oral antihyperglycemic drugs used in the management of type 2 diabetes: empagliflozin and metformin hydrochloride.

Indication:

Empagd-M is a combination of empagliflozin and metformin hydrochloride indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and metformin hydrochloride is appropriate. Empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease.

Formulation:

  • Tablets

Strength:

  • 12.5mg/500mg
  • 12.5mg/1000mg

Pack Size:

  • 1 x14’s
Empagd-M-packshot-copy